SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-023833
Filing Date
2020-05-11
Accepted
2020-05-11 06:47:22
Documents
14
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrx-8k_20200511.htm   iXBRL 8-K 37789
2 EX-99.1 amrx-ex991_6.htm EX-99.1 989737
3 GRAPHIC gfbwxya5hdoc000001.jpg GRAPHIC 2059
  Complete submission text file 0001564590-20-023833.txt   1200215

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrx-20200511.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20200511_lab.xml EX-101.LAB 18717
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20200511_pre.xml EX-101.PRE 11167
9 EXTRACTED XBRL INSTANCE DOCUMENT amrx-8k_20200511_htm.xml XML 3434
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 20862534
SIC: 2834 Pharmaceutical Preparations